The Ras-regulated Raf-MEK-ERK signaling pathway is deregulated in a variety of cancers, and activation of the terminal kinases in the ERK1/2 cascade results in their accumulation in the nucleus, where they phosphorylate various transcription factors to stimulate or repress gene expression (Kidger et al., 2018). The gene discussed is MAP2K7; the disease is cancer.